Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAdams Regulatory News (ADA)

Share Price Information for Adams (ADA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6.50
Bid: 5.00
Ask: 8.00
Change: 0.00 (0.00%)
Spread: 3.00 (60.00%)
Open: 6.50
High: 6.50
Low: 6.50
Prev. Close: 6.50
ADA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Final Results

17 Sep 2014 09:31

RNS Number : 9066R
Adams PLC
17 September 2014
 



 

 

 

 

Adams PLC

("Adams" or the "Company")

 

Final Results for the year ended 31st March 2014

 

We have pleasure in announcing final results for the financial year ended 31st March 2014.

During the year the Board, in cooperation with shareholders and external advisers, reviewed a range of investment opportunities and I am pleased to inform you that a short list has been decided upon and is being advanced. We hope that the final choice will deliver substantial value to shareholders.

In the meantime we have been careful to run the Company on a tight budget with a very low operating overhead. In preparation for the transaction phase, since the reporting period end we encouraged our warrant holders to exercise their warrant holdings which had the effect of bringing €150,000 of additional cash to our balance sheet.

We look forward to keeping shareholders apprised as developments arise.

N C P Nelson

Chairman

 

17 September 2014

 

The Annual Report and Accounts and AGM Notice has been posted to shareholders today.

 

 

Enquiries:

Adams plc

 

 

Tel: 07921 522920

NOMAD

Cairn Financial Advisers LLP

Sandy Jamieson

 

Tel: 020 7148 7900

 

Broker

Peterhouse Corporate Finance Limited

Heena Karani

Tel: 020 7469 3393

 

  

Investing Policy

In March 2013, Adams emerged following the restructuring and change of name from Carpathian Plc, formerly an AIM quoted property investing company. Fresh funding was sourced to enable Adams to continue as an AIM company with a view to making investments in the technology and life sciences sectors.

It is the Board's intention to seek to acquire a direct and/or an indirect interest in projects and assets in the biotechnology sector, however they will consider opportunities in the wider technology sector as well as opportunities that may arise in other sectors. The Company will focus on opportunities in UK or Europe but will consider possible opportunities anywhere in the world.

It is believed that an opportunity exists to acquire and consolidate holdings in Small and Medium sized Enterprises (SME's) operating in these sectors, with the intention of creating value for Shareholders. Initially, the Company's focus will be searching for companies where there may be a number of opportunities to acquire interests in undervalued or pre-commercialisation technologies which when applied produce cost savings or revenue enhancement for customers. Early acquisition of these innovative technologies should provide maximum returns for Shareholders.

The Directors see this sector as having considerable growth potential for the foreseeable future and many of the prospects they have identified are in this sector. The Directors will focus on early stage investments and believe that any investment target will have at least one of four key components: a strong management team; an innovative product proposal; revenue enhancing or cost saving capabilities; and high growth potential.

The Company may invest by way of purchasing quoted shares in appropriate companies, outright acquisition or by the acquisition of assets, including the intellectual property, of a relevant business, or by entering into partnerships or joint venture arrangements. Such investments may result in the Company acquiring the whole or part of a company or project (which in the case of an investment in a company may be private or listed on a stock exchange, and which may be pre-revenue), and such investments may constitute a minority stake in the company or project in question. The Company will not have a separate investment manager.

The Company may be both an active and a passive investor depending on the nature of the individual investments. The Board will place no minimum or maximum limit on the length of time that any investment may be held and therefore a short term disposal of any investments cannot be ruled out.

The Directors will however ensure that any investments meet strict due diligence criteria and the primary focus will be on companies post viability testing phase, to mitigate risk associated with early stage investment. This will not preclude the Company from considering investments in suitable projects in other regions and sectors where there are high-growth opportunities.

 

ADAMS PLC

Statement of Comprehensive Income

Year ended

 

Period ended

Notes

€'000

€'000

Impairment of loans to subsidiary

10

-

(9,887)

Impairment of interest receivable from subsidiary

10

-

(18,128)

Net foreign exchange (loss)

(2)

(363)

Administrative expenses

5

(101)

(88)

Other income

-

125

Net change in fair value of financial assets at fair value through profit or loss

9

(18)

-

───────

───────

Operating loss

5

(121)

(28,341)

Finance income

6

-

20,155

───────

───────

Loss on ordinary activities before taxation

(121)

(8,186)

Tax on loss on ordinary activities

7

───────

───────

Loss for the year

(121)

(8,186)

───────

───────

Total comprehensive loss for the year

(121)

(8,186)

═══════

═══════

Basic and diluted loss per share

15

(1)€c

(260)€c

═══════

═══════

 

ADAMS PLC

Statement of Financial Position

31 March 2014

31 March 2013

Notes

€'000

€'000

Assets

Non-current assets

Investments

9

14

115

───────

───────

Current assets

Trade and other receivables

11

7

11

Cash and cash equivalents

12

117

139

───────

───────

124

150

───────

───────

Total assets

138

265

═══════

═══════

Equity and Liabilities

Called up share capital

14

2,448

2,448

Share premium

14

133

133

Accumulated deficit

(2,456)

(2,335)

───────

───────

Total equity

125

246

───────

───────

Current liabilities

Trade and other payables

13

13

19

───────

───────

Total current liabilities

13

19

───────

───────

Total liabilities

13

19

──────-

───────

Total equity and liabilities

138

265

═══════

═══════

 

ADAMS PLC

Statement of Changes in Equity

Share

Capital

Share

Premium

Accumulated

(Losses)

Total

Notes

€'000

€'000

€'000

€'000

At 1 January 2012

2,309

42,522

(31,474)

13,357

Changes in equity

Total comprehensive loss

-

-

(8,186)

(8,186)

Dividends declared

8

-

-

(5,197)

(5,197)

Issue of shares

139

133

-

272

Reconstruction

-

(42,522)

42,522

-

───────

───────

───────

───────

At 31 March 2013

2,448

133

(2,335)

246

═══════

═══════

═══════

═══════

 

At 1 April 2013

2,448

133

(2,335)

246

Changes in equity

Total comprehensive loss

-

-

(121)

(121)

───────

───────

───────

───────

At 31 March 2014

2,448

133

(2,456)

125

═══════

═══════

═══════

═══════

 

ADAMS PLC

Statement of Cash Flows

Year ended

Period ended

31 March 2014

31 March 2013

€'000

€'000

Net cash from operating activities

1

(123)

(29,781)

Cash flows from investing activities

Receipts from sales of investments/payments to acquire investments

101

(115)

Interest received

-

27

Loan (advance to)/repayment from subsidiary

-

(9,723)

───────

───────

Net cash used in investing activities

101

(9,811)

───────

───────

Cash flows from financing

Issue of ordinary share capital

-

272

Dividends paid

-

(5,197)

───────

───────

Net cash from financing activities

-

(4,925)

───────

───────

Net (decrease) in cash and cash equivalents

(22)

(44,517)

Cash and cash equivalents at beginning of period

139

44,656

───────

───────

Cash and cash equivalents at end of period

117

139

═══════

═══════

 

ADAMS PLCNotes to the Statements of Cash Flows

1

Reconciliation of operating loss to net cash outflow from operating activities

 

Year ended 31 March 2014

Period ended 31 March 2013

 

€'000

€'000

 

 

Loss for the year

(121)

(8,186)

 

Net other finance income

-

(20,155)

 

Impairment of investments and loans receivable

-

28,031

 

Decrease in trade and other receivables

4

384

 

(Decrease) in trade and other payables

(6)

(29,855)

 

───────

───────

Net cash outflow from operating activities

(123)

(29,781)

 

═══════

═══════

2

Analysis of net cash

1 April 2013

Cash flow

Other non-cash changes

31 March 2014

€'000

€'000

€'000

€'000

Net cash:

Cash at bank and in hand

139

(22)

-

117

───────

───────

───────

───────

Liquid resources:

Current asset investments

-

-

-

-

───────

───────

───────

───────

Debt:

Debts falling due after one year

-

-

-

-

───────

───────

───────

───────

Net cash

139

(22)

-

117

═══════

═══════

═══════

═══════

3

Reconciliation of net cash flow to movement in net cash

Year ended 31 March 2014

Period ended 31 March 2013

 

€'000

€'000

Decrease in cash in the year/period

(22)

(44,517)

───────

───────

Movement in net cash in the year/period

(22)

(44,517)

 

Opening net cash

139

44,656

───────

───────

Closing net cash

117

139

═══════

═══════

 

ADAMS PLC

Notes to the Financial Statements

 

 

1 General information

Adams PLC is a company incorporated and domiciled in the Isle of Man. The address of the registered office is disclosed on the company information page at the front of the annual report. The principal activities of the Company are described in the directors' report.

2 Summary of significant accounting policies

The principal accounting policies applied in the preparation of these financial statements are set out below.

2.1 Basis of preparation

The financial statements have been prepared in accordance with International Financial Reporting Standards (IFRS). IFRS comprises of standards issued by the International Accounting Standards Board (IASB) and the interpretations issued by the International Financial Reporting Interpretations Committee (IFRIC) as adopted by the European Union (EU).

Preparation of financial statements

The preparation of financial statements in conformity with IFRS requires the use of certain critical accounting estimates. It also requires management to exercise its judgment in the process of applying the Company's accounting policies. The areas involving a higher degree of judgment or complexity, or areas where assumptions and estimates are significant to the financial statements are disclosed in Note 4.

New and amended standards adopted by the Company

There are no IFRSs or IFRIC interpretations that are effective for the first time for the financial year beginning on or after 1 April 2013 that would be expected to have a material impact on the Company.

Standards, interpretations and amendments to published standards that are not yet effective.

The following new standards, amendments to standards and interpretations have been issued, but are not effective for the financial year beginning 1 April 2013 and have not been early adopted:

Reference

Title

Summary

Application date of standard

Application date of Group

Amendments to IFRS 2, IFRS 3

Amendments resulting from Annual Improvements 2010-12 Cycle

IFRS 2: clarifies definition of vesting conditions

IFRS 3: clarifies contingent consideration in a business combination

1 July 2014

1 July 2014

Amendments to IAS 19

Defined Benefit Plans: Employee Contributions

Clarifies that the treatment of contributions when they are independent of the number of years of service

Periods commencing on or after 1 July 2014

1 January 2015

IFRS 9

Financial Instruments

Revised standard for accounting for financial instruments

Periods commencing on or after 1 January 2015

1 January 2015

2.1 Basis of preparation (continued)

Standards, interpretations and amendments to published standards that are not yet effective (continued)

 

IAS 36

Impairment of assets

Limited scope amendments to disclosure requirements

Periods commencing on or after 1 January 2014

1 January 2014

IAS 39

Hedge accounting and novation of derivatives

Provides relief from discontinuing hedge accounting when novation of a hedging instrument to a central counterparty meets specified criteria

Periods commencing on or after 1 January 2014

1 January 2014

IFRIS 21

Accounting for levies imposed by governments

Clarifies that the obligating event giving rise to a liability to pay a levy is the activity described in the relevant legislation that triggers payment of the levy

Periods commencing on or after 1 January 2014

1 January 2014

IFRS 10, IFRS 12, IAS 27

Exception from consolidation for "investment entities"

Amendments have been made to define an "investment entity" and to introduce an exception from consolidation and the required disclosures

Periods commencing on or after 1 January 2014

1 January 2014

IAS 32

Financial instruments: Presentation

Clarifies the requirements for offsetting of financial assets and financial liabilities

Periods commencing on or after 1 January 2014

1 January 2014

IFRS 14

Regulatory deferral accounts

Aims to enhance the comparability of financial reporting by entities subject to rate-regulations

Periods commencing on or after 1 January 2016

1 January 2016

 

2.2 Going concern

The financial statements have been prepared on a going concern basis.

When assessing the foreseeable future, the Directors have looked at a period of at least twelve months from the date of approval of this report. The forecast cash-flow requirements are to be financed by funds held at the date of this report.

After making enquiries, the Directors firmly believe that the Company has adequate resources to continue in operational existence for the foreseeable future. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

2.3 Compliance with accounting standards

The financial statements are prepared in accordance with applicable accounting standards.

2.4 Finance income

Finance income represents amounts receivable from related parties and banks.

2.5 Investments

Listed investments are designated at fair value through profit or loss.

2.6 Deferred taxation

Deferred taxation is provided in full in respect of taxation deferred by timing differences between the treatment of certain items for taxation and accounting purposes. The deferred tax balance has not been discounted.

A net deferred tax asset is recognised only if it can be regarded as more likely than not that there will be suitable taxable profits from which the future reversal of the underlying timing differences can be deducted.

 

2.7 Fair values

The carrying amounts of the financial assets and liabilities such as cash and cash equivalents, receivables and payables of the company at the statement of financial position date approximated their fair values, due to relatively short term nature of these financial instruments.

2.8 Trade payables and other non-derivative financial liabilities including long term payables

Trade payables and other creditors are non-interest bearing and are measured at cost.

2.9 Equity

Ordinary shares are classified as equity. Incremental costs directly attributable to the issue of new shares or options are shown in equity as a deduction, net of tax, from proceeds.

2.10 Cash and cash equivalents

Cash and cash equivalents include cash in hand, deposits held on call with banks, other short-term highly liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities on the statement of financial position.

2.11 Provisions

Provisions are recognised when the Company has a present obligation as a result of a past event, and it is probable that the Company will be required to settle that obligation. Provisions are measured at the Directors' best estimate of the expenditure required to settle the obligation at the statement of financial position date, and are discounted to present value where the effect is material.

2.12 Taxation

The charge for current tax is based on the results for the period as adjusted for items which are non-assessable or disallowed. It is calculated using rates that have been enacted or substantively enacted by the balance sheet date.

 

 

 

2.13 Foreign currencies

The functional currency of the Company is considered to be the Euro. It is the currency of the primary economic environment in which it operates. For the purpose of the financial statements, the results and financial position of the Company are presented in Euros as the Company is listed on AIM and its share price is quoted in Euros.

3 Financial risk management

The Company may use a limited number of financial instruments, comprising cash, short-term deposits and various items such as other receivables and other payables, which arise directly from operations. The Company does not trade in financial instruments.

 

3.1 Financial risk factors

The Company's activities may expose it to a variety of financial risks: foreign exchange risk, and credit risk. The Company's overall risk management programme focuses on the unpredictability of financial markets and seeks to minimise potential adverse effects on the Company's financial performance.

 

a) Foreign exchange risk

The Company incurs expenses subject to foreign currency fluctuations.

 

b) Credit risk

Credit risk arises from cash and cash equivalents and deposits with banks and other financial institutions as well as credit exposures to wholesale and retail customers, including outstanding receivables. The credit risk on liquid funds is limited because the counterparties are banks with high credit ratings assigned by international credit-rating agencies.

 

c) Interest rate risk

The Company does not have any borrowings other than its debentures which are at a fixed rate of interest and therefore there is currently no risk associated with movements in market rates of interest.

 

d) Liquidity risk

The Company is careful to ensure that its loans and investments can be realised prior to the due date for the repayment of the debentures. This applies equally to the underlying investments of the companies or projects in which the company invests.

 

e) Capital risk

The Company takes great care to protect its capital investments. Significant due diligence is undertaken prior to making any investment. The investment is closely monitored and wherever possible risks of a capital nature are insured.

 

f) Market risk

 

The Company may operate in many different geographical markets. A general economic downturn at a global level, or in one of the world's leading economies, could impact on the company. In addition, terrorism and other hostilities, as well as disturbances in worldwide financial markets, could have a negative effect on the company. Regulatory requirements, taxes, tariffs and other trade barriers, price or exchange controls or other governmental policies could also limit the company's operations. These risks are also applicable to most companies and the risk that Adams PLC will be more affected than the majority of companies is assessed as small.

3.2 Capital risk management

The Company's objectives when managing capital are to safeguard the Company's ability to continue as a going concern in order to provide returns for shareholders and benefits for other stakeholders and to maintain an optimal capital structure appropriate for its growth plans.

 

In order to maintain or adjust the capital structure the Company may issue new shares or alter debt levels.

 

4 Critical accounting estimates and judgments

Estimates and judgments are continually evaluated and are based on historical experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.

 

The Company makes estimates and assumptions concerning the future. Actual results could differ from those estimates. There are no estimates and assumptions that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next year.

 

5 Operating loss and expense analysis by nature

 

Year ended

31 March 2014

 

Period ended 31 March 2013

€'000

€'000

Operating loss is stated after charging:

Directors emoluments

26

146

Fees payable to the Company's auditor for the audit of the Company's annual accounts

13

9

Legal and professional fees

41

218

Investor relations

15

26

Other administrative expenses / release of provisions

6

(311)

───────

───────

Total administrative expenses

101

88

═══════

═══════

 

 

6 Finance income

Year ended

31 March 2014

Period ended 31 March 2013

€'000

€'000

Interest income from financial institutions

-

27

Interest income from subsidiary

-

20,128

───────

───────

-

20,155

═══════

═══════

 

7 Taxation

Year ended

31 March 2014

Period ended 31 March 2013

€'000

€'000

Total current tax

-

-

═══════

═══════

The tax rate applicable to the Company in the Isle of Man is 0% and therefore a full tax rate reconciliation of the relationship between the tax expense and accounting profit has not been included within these financial statements.

 

8 Dividends

Year ended

31 March 2014

Period ended 31 March 2013

€'000

€'000

Special dividend, paid 2013

-

5,197

───────

───────

-

5,197

═══════

═══════

 

 

9 Financial assets at fair value through profit and loss

Year ended 31 March 2014

Period ended 31 March 2013

 

€'000

€'000

 

 

Equity investments

14

115

 

Cash at bank

117

139

 

───────

───────

 

131

254

 

Net change in fair value of financial assets

at fair value through profit or loss

 

Movement in unrealised (gain)/losses on investments

(10)

8

Realised losses/(gains) on investments

28

(2)

 

───────

───────

 

18

6

 

═══════

═══════

 

 

10 Loan to former subsidiary

 

Following the annual review, a further impairment provision of €nil (2013 - €9.9 million) was made during the period.

 

During the period ended 31 March 2013 a provision of €18.1 million was also made for impairment of interest receivable from a former subsidiary. No such provision was necessary in the year ended 31 March 2014.

 

The Company and its former subsidiaries Carpathian Holdings S.à.r.l. and Carpathian Properties S.à.r.l. have entered into a Deed Poll. The Deed Poll provides for any amounts received by the Company and/or those Luxembourg Subsidiaries from other Subsidiaries of the Company (less costs incurred in connection with the solvent liquidation of the Subsidiaries) to be paid out to the Qualifying Shareholders.

 

The Directors are of the opinion that the subsidiaries could be excluded from consolidation on the grounds that there are severe long-term restrictions that substantially hinder the exercise of the rights of the parent over the assets or management of the subsidiaries.

 

11 Trade and other receivables

 

31 March 2014

31 March 2013

€'000

€'000

Prepayments and accrued income

7

11

───────

───────

7

11

═══════

═══════

 

The carrying amount of other current assets approximates to its fair value.

 

12 Cash and cash equivalents

For the purposes of the Statement of Cash Flows, cash and cash equivalents include cash at banks and on hand and deposits with banks. Cash and cash equivalents at the end of the reporting period as shown in the Statement of Cash Flows can be reconciled to the related items in the Statement of Financial Position as follows:

 

31 March 2014

31 March 2013

€'000

€'000

Cash and cash equivalents

117

139

═══════

═══════

The carrying amount of cash and cash equivalents approximates to its fair value.

 

13 Trade and other payables

31 March 2014

31 March 2013

€'000

€'000

Trade payables

3

10

Accruals and deferred income

10

9

───────

───────

13

19

═══════

═══════

 

Accruals principally comprise amounts outstanding for ongoing expenses. The carrying amount of other payables approximates to its fair value.

 

14 Share capital and share premium

Number of shares issued and fully paid

Share capital

Share premium

€'000

€'000

At 1 January 2012 - Ordinary Shares

230,957,973

2,309

42,522

Capital reorganisation (see below)

(228,648,394)

-

(42,522)

Issue of new A shares

13,856,727

139

133

───────

───────

───────

At 31 March 2013

16,166,306

2,448

133

═══════

═══════

═══════

 

 

At 1 April 2013

 

 

16,166,306

 

 

2,448

 

 

133

───────

───────

───────

At 31 March 2014

16,166,306

2,448

133

═══════

═══════

═══════

A resolution was passed at the 2010 Annual General Meeting approving changes to the Articles of Association on 6 August 2010. In accordance with the Articles, the authorised share capital of the Company amounts to €3,575,000, comprising 350,000,000 Ordinary Shares of 1 euro cent each and 750,000,000 Unclassified Shares of 0.01 euro cent each.

On 8 March 2013 the Company reorganised its Ordinary Shares whereby every 100 of the existing Ordinary Shares of 1 euro cent each were consolidated into one new "A" Ordinary Share of €1.00 which in turn was then sub-divided into one new Ordinary Share with a par value of €0.01 and one Deferred Share with a par value of €0.99.

On 8 March 2013, the Company issued 13,856,813 "A" Ordinary Shares by way of a placing at 2.165 euro cents each to its shareholders.

 

As at 31 March 2014, 2,309,579 deferred shares of €0.99 par value each were outstanding.

Holders of the Ordinary Shares are entitled to receive dividends and other distributions and to attend and vote at any general meeting.

Holders of all other shares are entitled to receive dividends and other distributions declared on those shares, but are not entitled to any further right of participation in the profits of the Company and are not entitled to attend and vote at any general meeting unless the business of the meeting includes the consideration of a resolution for the winding-up of the Company.

 

15 Loss per share

Year ended

31 March 2014

Period ended 31 March 2013

€'000

€'000

Basic loss per share is calculated by dividing the loss attributable to equity shareholders by the weighted average number of ordinary shares in issue during the period:

Loss after tax attributable to equity holders of the Company

(121)

(8,186)

Weighted average number of ordinary shares

16,166,306

3,144,785

Basic and diluted loss per share

(1)€c

(260)€c

═══════

═══════

 

 

16 Directors' remunerations and fees

Year ended

31 March 2014

Period ended 31 March 2013

€'000

€'000

Remuneration for qualifying services

26

146

═══════

═══════

 

17 Employees

 

Number of employees

The average monthly number of employees (including Directors) during the year was:

Year ended

31 March 2014

Period Ended 31 March 2013

Number

Number

Directors

2

4

───────

───────

2

4

═══════

═══════

 

 

Employment costs

Year ended 31 March 2014

Period Ended 31 March 2013

€'000

€'000

Directors remuneration

26

146

═══════

═══════

 

 

18 Control

At the date of the annual report, in the Directors opinion there is no one controlling party. The Directors owned none of the share capital of the Company as at 31 March 2014.

 

19 Related party relationships and transactions

The Company has related party relationships with its subsidiaries, companies it has an investment in and transactions with companies that have common management.

 

During the year, the Company entered into the following transactions with related parties:

 

2014

2014

2013

2013

Payables

Income/

(Expenses)

Payables

Income/

(Expenses)

€'000

€'000

€'000

€'000

Trading transactions

Accounting and administration fee charged by IOMA Fund and Investment Management Ltd

(2)

(8)

-

-

Management fees receivable from Carpathian Eta Kft

-

-

-

125

Management fees payable to Carpathian Asset Management Limited

-

-

-

(18)

───────

───────

───────

───────

(2)

8

-

107

═══════

═══════

═══════

═══════

 

18 Contingent liabilities

The Company has no contingent liabilities in respect of legal claims arising from the ordinary course of business.

 

 

19 Capital commitments

There was no capital expenditure contracted for at the end of the year but not yet incurred.

 

 

20 Events after the reporting period

Following the year end 31 March 2014, the Company issued 6,928,406 ordinary shares as result of shareholders exercising warrants. Warrants were vested at a price of €0.02165 per warrant, and ordinary shares were issued on a one for one basis with warrants, resulting in €150,000 capital injection.

 

Following the year end 31 March 2014, the Company sold its remaining interest in its former subsidiaries, Carpathian Holdings sàrl and Carpathian Properties sàrl, for a nominal sum to the former portfolio asset manager, Carpathian Asset Management Limited, itself in the process of liquidation.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR QKODBFBKKCCD
Date   Source Headline
20th Dec 202310:15 amRNSHolding(s) in Company
23rd Nov 20237:00 amRNSHalf-year Report
26th Sep 20234:03 pmRNSHolding(s) in Company
18th Aug 20233:33 pmRNSResult of AGM
16th Aug 20231:04 pmRNSHolding(s) in Company
15th Aug 20233:37 pmRNSHolding(s) in Company
14th Jul 20237:00 amRNSFinal Results
9th Mar 20233:47 pmRNSAnnouncement by WANdisco
18th Jan 202312:00 pmRNSHolding(s) in Company
17th Jan 20234:18 pmRNSHolding(s) in Company
24th Nov 20227:00 amRNSHalf-year Report
26th Aug 20223:44 pmRNSResult of AGM
7th Jul 20227:00 amRNSFinal Results
26th Nov 20217:00 amRNSHalf-year Report
26th Aug 202111:29 amRNSResult of AGM
28th Jun 20217:00 amRNSFinal Results
27th May 20217:00 amRNSInvestment in Motif Bio Plc
7th May 202111:33 amRNSHolding(s) in Company
7th May 202111:30 amRNSHolding(s) in Company
7th May 20217:00 amRNSInvestment in Seeing Machines Limited
15th Apr 202112:48 pmRNSResult of Open Offer
26th Mar 20217:00 amRNSPlacing and Open Offer
26th Nov 20207:00 amRNSHalf-year Report
22nd Oct 202010:23 amRNSInvestment Commitment in C4X Discovery Holdings
21st Aug 202012:45 pmRNSResult of AGM
30th Jun 20207:00 amRNSFinal Results
19th Jun 20203:24 pmRNSAssignment of Shareholder Loan Facility
12th Jun 20204:41 pmRNSSecond Price Monitoring Extn
12th Jun 20204:36 pmRNSPrice Monitoring Extension
10th Jun 20207:00 amRNSInvestment
19th Mar 20203:41 pmRNSStatement re COVID-19
11th Mar 20209:41 amRNSChange of Registered Office
3rd Jan 20207:00 amRNSInvestment
17th Dec 20198:57 amRNSDisposal
28th Nov 20197:00 amRNSHalf-year Report
9th Aug 201911:59 amRNSResult of AGM
3rd Jul 20197:00 amRNSFinal Results
29th Jan 20191:26 pmRNSShareholder Loan
27th Nov 20187:00 amRNSHalf-year Report
10th Aug 20182:01 pmRNSResult of AGM
26th Jun 20187:03 amRNSChange of Currency and AGM Proposals
26th Jun 20187:00 amRNSFinal Results
4th Jun 20189:56 amRNSHolding(s) in Company
4th Jun 20189:48 amRNSHolding(s) in Company
15th Dec 201712:55 pmRNSInvestment
28th Nov 20177:00 amRNSHalf-year Report
27th Nov 20172:07 pmRNSInvestment
6th Oct 201712:28 pmRNSDisposal
11th Sep 20175:06 pmRNSInvestment
8th Sep 20175:04 pmRNSResult of AGM and EGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.